A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

NCT04982237 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

445

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

BIOLOGICAL: AK104
DRUG: paclitaxel
DRUG: carboplatin
DRUG: cisplatin
DRUG: bevacizumab
DRUG: Placebo

Sponsor

Akeso